FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot
An mRNA (messenger ribonucleic acid) influenza biologic developed by Moderna, Inc. is scheduled to be reviewed today by a U.S. Food and Drug Administration (FDA) advisory panel. The Vaccines and Related Biological Products Advisory Committee ((VRBPAC) will evaluate data on Moderna’s mFlusiva (formerly known as mRNA-1010) to determine if the product provides superior relative vaccine […]
New Dengue Vaccine Suspended in Brazil After Severe Adverse Event Reports
Brazil’s Ministry of Health and the National Health Surveillance Agency (ANVISA) suspended a mass vaccination campaign using a new dengue vaccine developed by a Brazilian biomedical research center after severe adverse events, including deaths, were associated with certain batches of the vaccine. Authorities have opened an investigation into the incidents while continuing to assess the […]
AI-Fabricated Citations Infiltrating Medical Literature May Influence How Doctors Treat Patients
A first-of-its-kind audit of 2.5 million academic papers, published on May 7, 2026 in The Lancet, has identified more than 4,000 papers containing fake references that could not be traced to real publications. The audit analyzed over 97 million references across 2.5 million academic papers, marking the first academic study to examine the scale of […]
Executive Order Directs CDC to Reduce Number of Recommended Childhood Vaccines
On May 29, 2026, President Trump signed an executive order titled “Realigning United States Core Childhood Vaccine Recommendations With Best Practices from Peer, Developed Countries” endorsing a scientific assessment done earlier this year by the U.S. Department of Health and Human Services (DHHS) calling for a reduction in the number of recommended vaccines for children […]
Scientists Creating mRNA Biologics with Added Aluminum Adjuvant
Scientists at Boston Children’s Hospital in Massachusetts have developed an experimental mRNA biologic technology that they say produced longer-lasting immune responses in animal studies without the use of additional booster shots. The 2026 study was published in Nature Immunology.1 The research looked at a challenge in mRNA technology on how to make protection last longer […]
Ebola Bundibugyo Vaccines in Development Four Months Before Outbreak
An Ebola outbreak in the Ituri province of the Democratic Republic of the Congo (DRC) was confirmed by the Africa Centers for Disease Control and Prevention (Africa CDC) on May 15, 2026. Through laboratory analysis, health officials confirmed that the outbreak is caused by the Bundibugyo ebola strain, for which there is no vaccine currently […]